Immunohistochemical localization of DARPP32 in striatal projection neurons and striatal interneurons in pigeons

Journal of Chemical Neuroanatomy

Volumn 16, Issue 1, 1998, Pages 17-33

  Reiner, Anton ^a   Perera, Minoli ^a   Paullus, Rodney ^a   Medina, Loreta ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

Basal ganglia; Cholinergic; Dopaminoceptive; Enkephalin; Neuropeptide Y; Striatum; Substance P

Indexed keywords

ANIMAL TISSUE; ARTICLE; CHOLINERGIC TRANSMISSION; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; NERVE FIBER; NOCICEPTION; NONHUMAN; PIGEON; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALS; BASAL GANGLIA; COLUMBIDAE; DOPAMINE; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MESENCEPHALON; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; PHOSPHOPROTEINS; TELENCEPHALON;

EID: 0032464779     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-0618(98)00056-8     Document Type: Article

References (91)

1. Ajima A., Yamaguchi T., Kato T. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 518:1990;193-198.
2. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
3. Altar C.A., Hauser K. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons. Brain Res. 410:1987;1-11.
4. Anderson K.D., Reiner A. The extensive co-occurrence of substance P and dynorphin in striatal projection neurons: an evolutionarily conserved feature of basal ganglia organization. J. Comp. Neurol. 295:1990;339-369.
5. Anderson K.D., Reiner A. The distribution and relative abundance of neurons in the pigeon forebrain containing somatostatin, neuropeptide Y or both. J. Comp. Neurol. 299:1990;261-282.
6. Anderson K.D., Reiner A. Striatonigral projection neurons: a retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons. J. Comp. Neurol. 303:1991;658-673.
7. Anderson K.D., Reiner A. Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons. Brain Res. 568:1991;235-243.
8. Angulo J.A., McEwen B.S. Molecular aspects of neuropeptide regulation and function in the corpus striatum and nucleus accumbens. Brain Res. Rev. 19:1994;1-28.
9. Aoki C., Pickel V.M. Neuropeptide Y-containing neurons in the rat striatum: ultrastructure and cellular relations with tyrosine hydroxylase-containing terminals and with astrocytes. Brain Res. 459:1988;205-225.
10. Aronin N., DiFiglia M., Graveland G.A., Schwartz W.J., Wu J.Y. Localization of immunoreactive enkephalins in GABA synthesizing neurons of the rat neostriatum. Brain Res. 300:1984;376-380.
11. Ball G.F., Casto J.M., Balthazart J. Autoradiographic localization of D1-like dopamine receptors in the forebrain of male and female Japanese quail and their relationship with immunoreactive tyrosine hydroxylase. J. Chem. Neuroanat. 9:1995;121-133.
12. Beckstead R.M. Association of dopamine D1 and D2 receptors with specific cellular elements in the basal ganglia of the cat: the uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons. Neuroscience. 27:1988;851-863.
13. Besson M.J., Graybiel A.M., Quinn B. Co-expression of neuropeptides in the cat's striatum: an immunohistochemical study of substance P, dynorphin B and enkephalin. Neuroscience. 39:1990;33-58.
14. 2 dopamine receptor cDNA. Nature. 336:1988;783-787.
15. Casto J.M., Ball G.F. Characterization and localization of D1 dopamine receptors in the sexually dimorphic vocal control nucleus, area X, and the basal ganglia of European starlings. J. Neurobiol. 25:1994;767-780.
16. 2 receptor: two molecular forms generated by alternative splicing. EMBO J. 8:1989;4025-4034.
17. Damsma G., Tham C.S., Robertson G.S., Fibiger H.C. Dopamine D1 receptor stimulation increases striatal acetylcholine release in the rat. European J. Pharmacol. 186:1990;335-338.
18. Dawson V.L., Dawson T.M., Wamsley J.K. Muscarinic and dopaminergic receptor subtypes on striatal cholinergic interneurons. Brain Res. Bull. 25:1990;903-912.
19. 1 dopamine receptor. Nature. 347:1990;72-76.
20. Dietl M.M., Palacios J.M. Neurotransmitter receptors in the avian brain, I: dopamine receptors. Brain Res. 439:1988;354-359.
21. Demchyshyn L.L., Sugamori K.S., Lee F.J.S., Hamadanizadeh S.A., Hyman H.B. The dopamine D1D receptor: cloning and characterization of three pharmacolgically distinct D1-like receptors from Gallus domesticus. J. Biol. Chem. 270:1995;4005-4012.
22. Drukarch B., Schepens E., Stoof J.C. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway. Neuroscience. 37:1990;1-9.
23. Durstewitz D., Kröner S., Hemmings H.C., Güntürkün O. The dopaminergic innervation of the pigeon telencephalon: distribution of DARPP32 and co-occurrence with glutamate decarboxylase and tyrosine hydroxylase. Neuroscience. 83:1998;763-779.
24. Figueredo-Cardenas G., Morello M., Sancesario G., Bernardi G., Reiner A. Colocalization of somatostatin, neuropeptide Y, NADPH-diaphorase and neuronal nitric oxide synthase in striatal interneurons in rats. Brain Res. 735:1996;317-324.
25. Freund T.F., Powell J.F., Smith A.D. Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience. 13:1984;1189-1215.
26. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
27. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J. Jr., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
28. Gerfen, C.R., Keefe, K.A., Steiner, H., 1996. D1 and D2 dopamine receptor-mediated gene regulation in the striatum. In: Merchant K. (Ed.), Pharmacological Regulation of Gene Expression in the CNS. CRC Press, Boca Raton, FL, pp. 3-24.
29. Gerfen, C.R., Young III, W.S., 1988. Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res. 460, 161-167.
30. 2 dopamine receptor isoforms. Nature. 342:1989;923-926.
31. Grandy D.K., Marchionni M.A., Makam H. et al. Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc. Natl. Acad. Sci. USA. 86:1989;9762-9766.
32. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-253.
33. Harrison M.B., Wiley R.G., Wooten G.F. Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res. 528:1990;317-322.
34. Harrison M.B., Wiley R.G., Wooten G.F. Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res. 590:1992;305-310.
35. Hemmings H.C., Nairn A.C., Aswad D.W., Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions, II: purification and characterization of the phosphoprotein from bovine caudate nucleus. J. Neurosci. 4:1984;99-110.
36. Hemmings H.C. Jr., Walaas S.I., Ouimet C.C., Greengard P. Dopaminergic regulation of protein phosphorylation in the striatum: DARPP-32. Trends Neurosci. 10:1987;377-383.
37. Hemmings, H.C. Jr., Nairn, A.C., Bibb, J.A., Greengard, P., 1995. Signal transduction in the striatum: DARPP32, a molecular integrator of multiple signaling pathways. In: Ariano, M.A., Surmeier, D.J. (Eds.), Molecular and Cellular Mechanisms of Neostriatal Function. Springer-Verlag, Berlin, pp. 283-297.
38. + conductance. J. Neurosci. 17:1997;3334-3342.
39. Hong J.S., Yoshikawa K., Kanamatsu T., Sabol S.L. Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fed. Proc. 44:1985;2535-2539.
40. Johnson C.D., Epstein M.L. Monoclonal antibodies and polyvalent antiserum to chicken choline acetyltransferase. J. Neurochem. 46:1986;968-976.
41. Karle E., Anderson K.D., Medina L., Reiner A. Light and electron microscopic immunohistochemical study of dopaminergic terminals in pigeon striatum using antisera against tyrosine hydroxylase and dopamine. J. Comp. Neurol. 369:1996;109-124.
42. Karle E.J., Anderson K.D., Reiner A. Ultrastructural double-labeling demonstrates synaptic contacts between dopaminergic terminals and substance P-containing striatal neurons in pigeons. Brain Res. 572:1992;303-309.
43. Karle E.J., Anderson K.D., Reiner A. Dopaminergic terminals form synaptic contacts with enkephalinergic striatal neurons in pigeons: an electron microscopic study. Brain Res. 646:1994;149-156.
44. Kawaguchi Y., Wilson C.J., Emson P.C. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J. Neurosci. 10:1990;3421-3438.
45. Kerkerian L., Bosler O., Pelletier G., Nieoullon A. Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: Immunohistochemical evidence. Neurosci. Lett. 66:1986;106-112.
46. Kita H., Kitai S.T. Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations. Brain Res. 447:1988;346-352.
47. Kubota Y., Inagaki S., Kito S. Innervation of substance P neurons by catecholaminergic terminals in the neostriatum. Brain Res. 375:1986;163-167.
48. Kubota Y., Inagaki S., Kito S., Takagi H., Smith A.D. Ultrastructural evidence of dopaminergic input to enkephalinergic neurons in rat neostriatum. Brain Res. 367:1986;374-378.
49. Kubota Y., Inagaki S., Kito S., Wu J.Y. Dopaminergic axons directly make synapses with GABAergic neurons in the rat neostriatum. Brain Res. 406:1987;147-156.
50. Langley K.C., Bergson C., Greengard P., Ouimet C.C. Co-localization of the D1 dopamine receptor in a subvset of DARPP-32-containing neurons in rat caudate-putamen. Neuroscience. 78:1997;977-983.
51. Le Moine, C., Bloch, B., 1995a. Anatomical and cellular analysis of dopamine receptor gene expression in striatal neurons. In: Ariano, M.A., Surmeier, D.J. (Eds.), Molecular and Cellular Mechanisms of Neostriatal Function. Springer-Verlag, Berlin, pp. 45-57.
52. Le Moine C., Bloch B. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:1995;418-426.
53. Le Moine C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. USA. 88:1991;4205-4209.
54. Le Moine C., Tison F., Bloch B. D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci. Lett. 117:1990;248-252.
55. Lehmann J., Langer S.Z. The striatal cholinergic interneuron: synaptic target of dopaminergic terminals. Neuroscience. 10:1983;1105-1120.
56. Lindefors N., Brené S., Herrera-Marschitz M., Persson H. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons. Exp. Brain Res. 80:1990;489-500.
57. MacLennan A.J., Lee N., Vincent S.R., Walker D.W. D2 dopamine receptor mRNA distribution in cholinergic and somatostatinergic cells of the rat caudate-putamen and nucleus accumbens. Neurosci. Lett. 180:1994;214-218.
58. Medina L., Reiner A. Distribution of choline acetyltransferase immunoreactivity in the pigeon brain. J. Comp. Neurol. 342:1994;497-537.
59. Medina L., Reiner A. Neurotransmitter organization and connectivity of the basal ganglia in vertebrates: implications for the evolution of the basal ganglia. Brain Behav. Evol. 46:1995;235-258.
60. Monsma F.J. Jr., Mahan L.C., McVittie L.D., Gerfen C.R., Sibley D.R. Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc. Natl. Acad. Sci. USA. 87:1990;6723-6727.
61. Nishi A., Snyder G.L., Greengard P. Bidirectional regulation of DARPP32 phosphorylation by dopamine. J. Neurosci. 17:1997;8147-8155.
62. Normand E., Popovici T., Onteniente B. et al. Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons. Brain Res. 439:1988;39-46.
63. Nylander I., Terenius L.H. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways. Neuropharmacol. 9:1987;1295-1302.
64. Oertel W.H., Riethmuller G., Mugnaini E. et al. Opioid peptide-like immunoreactivity localized in GABAergic neurons of rat neostriatum and central amygdaloid nucleus. Life Sci. 33:1983;73-76.
65. Ohno Y., Sasa M., Takaori S. Co-existence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci. 40:1987;1937-1945.
66. Ouimet C.C., Greengard P. Distribution of DARPP-32 in the basal ganglia: an electron microscopic study. J. Neurocytol. 19:1990;39-52.
67. Ouimet C.C., LaMantia A.S., Goldman-Rakic P., Rakic P., Greengard P. Immunocytochemical localization of DARPP-32, a dopamine- and Cyclic-AMP-regulated phosphoprotein in the primate brain. J. Comp. Neurol. 323:1992;209-218.
68. Ouimet C.C., Miller P.E., Hemmings H.C. Jr., Walaas S.I., Greengard P. DARPP-32, A dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions, III: immunocytochemical localization. J. Neurosci. 4:1984;111-124.
69. Platt J.L., Michael A.F. Retardation of fading and enhancement of intensity of immunofluorescence by P-phenylenediamine. J. Histochem. Cytochem. 31:1983;840-842.
70. Reiner A. The co-occurrence of substance P-like immunoreactivity and dynorphin-like immunoreactivity in striatonigral and striatopallidal projection neurons in pigeons and turtles. Brain Res. 371:1986;155-161.
71. Reiner A., Anderson K.D. The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: conclusions based on recent findings. Brain Res. Rev. 15:1990;251-265.
72. Reiner A., Davis B.M., Brecha N.C., Karten H.J. The distribution of enkephalin-like immunoreactivity in the telencephalon of the adult and developing domestic chicken. J. Comp. Neurol. 228:1984;245-262.
73. Reiner A., Eldred W.D., Beinfeld M.C., Krause J.E. The co-occurrence of a substance P-like peptide and cholecystokinin-8 in a fiber system of turtle cortex. J. Neurosci. 5:1985;1527-1544.
74. Reiner A., Karten H.J., Solina A.R. Substance P: localization within paleostriatal-tegmental pathways in pigeons. Neuroscience. 9:1983;61-85.
75. Richfield E.K., Young A.B., Penney J.B. Comparative distribution of D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J. Comp. Neurol. 262:1987;446-463.
76. Ritter J.K., Schmidt C.J., Gibb J.W., Hanson G.R. Dopamine-mediated increases in nigral substance P-like immunoreactivity. Biochem. Pharmacol. 34:1985;3161-3166.
77. 3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra. Neurosci. Lett. 72:1986;265-271.
78. Schnabel R., Metzger M., Jiang S., Hemmings H.C., Greengard P., Braun K. Localization of dopamine D1 receptors and dopamineoceptive neurons in the chick forebrain. J. Comp. Neurol. 388:1997;146-168.
79. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
80. Sun, Z., Coffman, J., Reiner, A., 1998. Localization of dopamine D1A receptor mRNA in the domestic chick telencephalon. Soc. Neurosci. Abs. 24, in press.
81. 1. Nature. 350:1991;614-619.
82. Sunahara R.K., Niznik H.B., Weiner D.M. et al. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature. 347:1990;80-83.
83. Surmeier D.J., Song W.J., Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J. Neurosci. 16:1996;6579-6591.
84. Svenningsson P., Lindskog M., Rognoni F., Fredholm B.B., Greengard P., Fisone G. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependnent phosphorylation of DARPP32 in distinct populations of striatal projection neurons. Neuroscience. 84:1998;223-228.
85. Uchimura N., Higashi H., Nishi S. Hyperpolarizing and depolarizing actions of dopamine via D1 and D2 receptors on nucleus accumbens neurons. Brain Res. 375:1986;368-372.
86. 4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
87. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784.
88. Vuillet J., Kerkerian L., Kachidian P., Bosler O., Nieoullon A. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci. Lett. 100:1989;99-104.
89. Walaas S.I., Greengard P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions, I: regional and cellular distribution in the rat brain. J. Neurosci. 4:1984;84-98.
90. Young, W.S., III, Bonner, T.I., Brann, M.R., 1986. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA 83, 9827-9831.
91. 1 dopamine receptors. Nature. 347:1990;76-80.